Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.710
-0.210 (-4.27%)
Dec 5, 2025, 4:00 PM EST - Market closed
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 800 employees as of December 31, 2024. The number of employees increased by 300 or 60.00% compared to the previous year.
Employees
800
Change (1Y)
300
Growth (1Y)
60.00%
Revenue / Employee
$54,611
Profits / Employee
-$894,429
Market Cap
2.46B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RXRX News
- 20 hours ago - Jim Cramer: This Health Care Stock Has Been 'Horrendous' - Benzinga
- 1 day ago - 10 AI Stocks Worth Buying Right Now - The Motley Fool
- 4 days ago - Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025 - GlobeNewsWire
- 11 days ago - Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? - The Motley Fool
- 14 days ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 16 days ago - Is Recursion Pharmaceuticals a Meme Stock? - The Motley Fool
- 17 days ago - Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader? - Seeking Alpha
- 4 weeks ago - Recursion Pharmaceuticals, Inc. (RXRX) Q3 2025 Earnings Call Transcript - Seeking Alpha